These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688 [TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer. Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893 [TBL] [Abstract][Full Text] [Related]
9. Downstaging and Survival Associated with Neoadjuvant Immunotherapy Before Radical Cystectomy for Muscle-invasive Bladder Cancer. Grassauer J; Schmidt J; Cowan A; Gilbert SM; Chakiryan NH Eur Urol Oncol; 2024 Feb; 7(1):139-146. PubMed ID: 37453853 [TBL] [Abstract][Full Text] [Related]
10. Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study. Avudaiappan AP; Prabhakar P; Sandman MS; Rubens M; Garje R; Eldefrawy A; Manoharan M BMC Urol; 2024 Jul; 24(1):150. PubMed ID: 39049001 [TBL] [Abstract][Full Text] [Related]
11. Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients. van Hoogstraten LMC; van Gennep EJ; Kiemeney LALM; Witjes JA; Voskuilen CS; Deelen M; Mertens LS; Meijer RP; Boormans JL; Robbrecht DGJ; Beerepoot LV; Verhoeven RHA; Ripping TM; ; van Rhijn BWG; Aben KKH; Hermans TJN World J Urol; 2022 Jan; 40(1):111-118. PubMed ID: 34585294 [TBL] [Abstract][Full Text] [Related]
12. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822 [TBL] [Abstract][Full Text] [Related]
13. Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. Hensley PJ; Bree KK; Campbell MT; Alhalabi O; Kokorovic A; Miest T; Nogueras-Gonzalez GM; Gao J; Siefker-Radtke AO; Guo CC; Navai N; Dinney CP; Kamat AM J Urol; 2021 Nov; 206(5):1258-1267. PubMed ID: 34184926 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis. Soria F; Black PC; Fairey AS; Cookson MS; Yu EY; Kassouf W; Dall'Era MA; Sridhar SS; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Daneshmand S; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Shariat SF; Gontero P BJU Int; 2021 Jul; 128(1):79-87. PubMed ID: 33152179 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients. Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762 [TBL] [Abstract][Full Text] [Related]
18. Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. Møller CT; Støer NC; Blindheim A; Berge V; Tafjord G; Fosså SD; Andreassen BK BMC Cancer; 2022 Dec; 22(1):1301. PubMed ID: 36510166 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer. Mansour AM; Soloway MS; Eldefrawy A; Singal R; Joshi S; Manoharan M Can J Urol; 2015 Apr; 22(2):7690-7. PubMed ID: 25891331 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report. Rosenblatt R; Johansson M; Alamdari F; Sidiki A; Holmström B; Hansson J; Vasko J; Marits P; Gabrielsson S; Riklund K; Winqvist O; Sherif A World J Urol; 2017 Jun; 35(6):921-927. PubMed ID: 27738804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]